ERBB2 and breast cancer: The presence or absence of specific hormone receptors (HRs), such as oestrogen and progesterone receptors (ERs and PgRs, respectively), and the overexpression of the human epidermal growth factor receptor 2 (HER2) are the factors that determine the simplified immunohistochemistry-based BC molecular classifications [2].